Close Menu

synthetic genomics

The funding will help the company further develop its INSPECTR molecular diagnostic platform into a test that can be used in various settings.

Two new grants are helping the company develop its SHERLOCK and INSPECTR technologies as the basis for creating innovative diagnostics.